Dr. Michael Hardy has been hired as the next Executive Director of the Racing Medication & Testing Consortium.
In his new role, Dr. Hardy will be responsible for the management of the RMTC's Laboratory Accreditation and External Quality Assurance Program in conjunction with the new Horseracing Integrity and Welfare Unit. He will also be charged with the administration of the RMTC's Scientific Advisory Committee process, the monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, administrative oversight of RMTC-funded research projects, and coordinating RegVet CE programs.
Dr. Hardy will lead the efforts of the RMTC to educate Thoroughbred racing participants concerning the significant changes in the regulation of anti-doping and medication control to begin Jan. 1, 2023 with the implementation of the new Horseracing Integrity and Safety Authority ADMC program.
The RMTC selected Dr. Hardy based on his experience in developing regulatory safety initiative(s) for racehorses, management of pre- and post-race drug testing, research into emerging threats to the integrity of horse racing, and the regulation of horse racing in general.
“We are very pleased to have Dr. Hardy on board,” said RMTC Chair Alex Waldrop. “He has been working with the RMTC for years now, and that will enable him to hit the ground running in this new capacity, at a pivotal time for the RMTC and the entire horse racing industry.”
Hardy also continues in his position as Chief Association Veterinarian, and newly appointed Safety Director for Horseshoe Indianapolis, and as a member of the Breeders' Cup Veterinary Panel.
The post Dr. Michael Hardy Named Executive Director Of Racing Medication & Testing Consortium appeared first on Horse Racing News | Paulick Report.
